259 related articles for article (PubMed ID: 23352374)
21. Sentinel lymph node biopsy in pediatric soft tissue sarcoma patients: utility and concordance with imaging.
Alcorn KM; Deans KJ; Congeni A; Sulkowski JP; Bagatell R; Mattei P; Minneci PC
J Pediatr Surg; 2013 Sep; 48(9):1903-6. PubMed ID: 24074665
[TBL] [Abstract][Full Text] [Related]
22. ¹⁸F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas.
Eugene T; Corradini N; Carlier T; Dupas B; Leux C; Bodet-Milin C
Nucl Med Commun; 2012 Oct; 33(10):1089-95. PubMed ID: 22929116
[TBL] [Abstract][Full Text] [Related]
23. Is retroperitoneal lymph node dissection necessary for adult paratesticular rhabdomyosarcoma?
Hermans BP; Foster RS; Bihrle R; Little S; Sandler A; Einhorn LH; Donohue JP
J Urol; 1998 Dec; 160(6 Pt 1):2074-7. PubMed ID: 9817327
[TBL] [Abstract][Full Text] [Related]
24. Current management of paratesticular rhabdomyosarcoma.
Dangle PP; Correa A; Tennyson L; Gayed B; Reyes-Múgica M; Ost M
Urol Oncol; 2016 Feb; 34(2):84-92. PubMed ID: 26572723
[TBL] [Abstract][Full Text] [Related]
25. Rhabdomyosarcoma of testis and spermatic cord in children.
Brosman SA; Cohen A; Fay R
Urology; 1974 May; 3(5):568-72. PubMed ID: 4830633
[No Abstract] [Full Text] [Related]
26. [Current trends in the treatment of paratesticular rhabdomyosarcoma].
Debruyne FM; Bökkerink JP; de Vries JD; Holland R
Ned Tijdschr Geneeskd; 1985 Nov; 129(48):2310-3. PubMed ID: 4080019
[No Abstract] [Full Text] [Related]
27. Concomitant reconstruction of infrarenal aorta and inferior vena cava after en bloc resection of retroperitoneal rhabdomyosarcoma.
Anaya-Ayala JE; Cheema ZF; Davies MG; Lumsden AB; Reardon MJ
Vasc Endovascular Surg; 2011 Nov; 45(8):769-72. PubMed ID: 21914678
[TBL] [Abstract][Full Text] [Related]
28. Robotic retroperitoneal lymphadenectomy in paratesticular rhabdomyosarcoma.
Quiroz YY; Moncada E; Llorens E; Schwartzmann I; Caffarati J; Bujons A
J Pediatr Urol; 2022 Jun; 18(3):401-403. PubMed ID: 35410803
[TBL] [Abstract][Full Text] [Related]
29. Retroperitoneal lymph node staging in paratesticular rhabdomyosarcoma-are we meeting expectations?
Hamilton EC; Miller CC; Joseph M; Huh WW; Hayes-Jordan AA; Austin MT
J Surg Res; 2018 Apr; 224():44-49. PubMed ID: 29506850
[TBL] [Abstract][Full Text] [Related]
30. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
[TBL] [Abstract][Full Text] [Related]
31. [Paratesticular rhabdomyosarcoma. Report of 2 cases].
Pérez Herms S; Castellanos Acosta R; Cortadellas Angel R; Guzmán Fernańdez A; Ballesteros Sampol JJ
Actas Urol Esp; 1991; 15(5):491-4. PubMed ID: 1807133
[TBL] [Abstract][Full Text] [Related]
32. Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement.
Van den Bergh L; Lerut E; Haustermans K; Deroose CM; Oyen R; Isebaert S; Budiharto T; Ameye F; Mottaghy FM; Bogaerts K; Van Poppel H; Joniau S
Urol Oncol; 2015 Mar; 33(3):109.e23-31. PubMed ID: 25655681
[TBL] [Abstract][Full Text] [Related]
33. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
34. Additional Benefit of F-18 FDG PET/CT in the staging and follow-up of pediatric rhabdomyosarcoma.
Ricard F; Cimarelli S; Deshayes E; Mognetti T; Thiesse P; Giammarile F
Clin Nucl Med; 2011 Aug; 36(8):672-7. PubMed ID: 21716019
[TBL] [Abstract][Full Text] [Related]
35. Can we rely on PET in the follow-up of advanced seminoma patients?
Siekiera J; Małkowski B; Jóźwicki W; Jasiński M; Wronczewski A; Pietrzak T; Chmielowska E; Petrus A; Kamecki K; Mikołajczak W; Kraśnicki K; Chłosta P; Drewa T
Urol Int; 2012; 88(4):405-9. PubMed ID: 22507953
[TBL] [Abstract][Full Text] [Related]
36. Paratesticular rhabdomyosarcoma in childhood.
Raney RB; Hays DM; Lawrence W; Soule EH; Tefft M; Donaldson MH
Cancer; 1978 Aug; 42(2):729-36. PubMed ID: 354776
[TBL] [Abstract][Full Text] [Related]
37. PET for staging in rhabdomyosarcoma: an evaluation of PET as an adjunct to current staging tools.
Klem ML; Grewal RK; Wexler LH; Schöder H; Meyers PA; Wolden SL
J Pediatr Hematol Oncol; 2007 Jan; 29(1):9-14. PubMed ID: 17230060
[TBL] [Abstract][Full Text] [Related]
38. Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer.
Xu N; Wang M; Zhu Z; Zhang Y; Jiao Y; Fang W
Chin Med J (Engl); 2014; 127(4):607-13. PubMed ID: 24534208
[TBL] [Abstract][Full Text] [Related]
39. Paratesticular rhabdomyosarcoma: delayed effects of multimodality therapy and implications for current management.
Hughes LL; Baruzzi MJ; Ribeiro RC; Ayers GD; Rao B; Parham DM; Pratt CB; Kun LE
Cancer; 1994 Jan; 73(2):476-82. PubMed ID: 8293416
[TBL] [Abstract][Full Text] [Related]
40. Paratesticular rhabdomyosarcoma (RMS) and paraaortic lymphadenectomy.
Gamba PG; Cecchetto G; Katende M; Carli M; Sotti G; Guglielmi M
Eur J Pediatr Surg; 1994 Jun; 4(3):158-60. PubMed ID: 8086392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
